Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver

doi:10.3748/wjg.v11.i2.176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3917)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

327

HTML

3115

Figures (1-3)

266

Tables (1-1)

209

Sum=3917

Jan 14, 2005 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (53)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jan 14, 2005; 11(2): 176-181
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.176

Full Size Figure Download Figure

Figure 3 Disease-free survival analysis shows the differences in disease-free survival in patients with or without diffuse pattern of CD105 staining in non-tumorous livers. Five patients were excluded from the analysis because of hospital mortality or palliative resection with positive resection margins.

Citation: Ho JW, Poon RT, Sun CK, Xue WC, Fan ST. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. World J Gastroenterol 2005; 11(2): 176-181
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/176.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i2.176